- The US FDA refuses to approve AbbVie’s Parkinson’s disease therapy.Reuters
- FDA slams Abivin’s blockbuster-to-be Parkinson’s drugFiercePharma
- AbbVie submits regulatory update on Parkinson’s disease drug candidateYahoo Finance
- ABBV (NYSE: ABBV) stock drops as FDA rejects Parkinson’s treatmentSeeking Alpha
- FDA rejects approval of AbbVie’s Parkinson’s therapyNewsmax
- See full coverage on Google News
Comments